Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 31 Records) |
| Query Trace: Neoplasms and MYD88[original query] |
|---|
| Innate immunity gene polymorphisms and the risk of colorectal neoplasia. Carcinogenesis 2013 Nov 34 (11): 2512-20. Chang Cindy M, Chia Victoria M, Gunter Marc J, Zanetti Krista A, Ryan Bríd M, Goodman Julie E, Harris Curtis C, Weissfeld Joel, Huang Wen-Yi, Chanock Stephen, Yeager Meredith, Hayes Richard B, Berndt Sonja I, |
| Functional TLR5 genetic variants affect human colorectal cancer survival. Cancer research 2013 Dec 73 (24): 7232-42. Klimosch Sascha N, Försti Asta, Eckert Jana, Knezevic Jelena, Bevier Melanie, von Schönfels Witigo, Heits Nils, Walter Jessica, Hinz Sebastian, Lascorz Jesus, Hampe Jochen, Hartl Dominik, Frick Julia-Stefanie, Hemminki Kari, Schafmayer Clemens, Weber Alexander N |
| Mutation and expression analysis of the IDH1, IDH2, DNMT3A, and MYD88 genes in colorectal cancer. Gene 2014 Aug 546 (2): 263-70. Li Wen-Liang, Xiao Mei-Sheng, Zhang Deng-Feng, Yu Dandan, Yang Run-Xiang, Li Xiao-Yan, Yao Yong-Ga |
| Somatic mutations in MYD88 and CXCR4 are determinants of clinical presentation and overall survival in Waldenstrom macroglobulinemia. Blood 2014 May 123 (18): 2791-6. Treon Steven P, Cao Yang, Xu Lian, Yang Guang, Liu Xia, Hunter Zachary |
| Predictive model for risk of severe gastrointestinal toxicity following chemotherapy using patient immune genetics and type of cancer: a pilot study. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2015 May 23 (5): 1233-6. Coller Janet K, White Imogen A, Logan Richard M, Tuke Jonathan, Richards Alison M, Mead Kelly R, Karapetis Christos S, Bowen Joanne |
| Innate Immune Signalling Genetics of Pain, Cognitive Dysfunction and Sickness Symptoms in Cancer Pain Patients Treated with Transdermal Fentanyl. PloS one 2015 10 (9): e0137179. Barratt Daniel T, Klepstad Pål, Dale Ola, Kaasa Stein, Somogyi Andrew |
| Genetics and Prognostication in Splenic Marginal Zone Lymphoma: Revelations from Deep Sequencing. Clinical cancer research : an official journal of the American Association for Cancer Research 2015 Sep 21 (18): 4174-83. Parry Marina, Rose-Zerilli Matthew J J, Ljungström Viktor, Gibson Jane, Wang Jun, Walewska Renata, Parker Helen, Parker Anton, Davis Zadie, Gardiner Anne, McIver-Brown Neil, Kalpadakis Christina, Xochelli Aliki, Anagnostopoulos Achilles, Fazi Claudia, Gonzalez de Castro David, Dearden Claire, Pratt Guy, Rosenquist Richard, Ashton-Key Margaret, Forconi Francesco, Collins Andrew, Ghia Paolo, Matutes Estella, Pangalis Gerassimos, Stamatopoulos Kostas, Oscier David, Strefford Jonathan |
| Genetic Landscapes of Relapsed and Refractory Diffuse Large B-Cell Lymphomas. Clinical cancer research : an official journal of the American Association for Cancer Research 2015 Dec . Morin Ryan D, Assouline Sarit E, Alcaide Miguel, Mohajeri Arezoo, Johnston Rebecca L, Chong Lauren, Grewal Jasleen, Yu Stephen, Fornika Daniel, Bushell Kevin, Holm Nielsen Torsten, Petrogiannis-Haliotis Tina, Crump Michael, Tosikyan Axel, Grande Bruno M, Macdonald David, Rousseau Caroline, Bayat Maryam, Sesques Pierre, Froment Remi, Albuquerque Marco, Monczak Yuri, Klein-Oros Kathleen, Greenwood Celia, Riazalhosseini Yasser, Arseneault Madeleine, Camlioglu Errol, Constantin André Marc, Pan-Hammarström Qiang, Peng Rou-Jun, Mann Koren K, Johnson Nathalie |
| MYD88, CD79B, and CARD11 gene mutations in CD5-positive diffuse large B-cell lymphoma. Cancer 2016 Dec . Takeuchi Toshifumi, Yamaguchi Motoko, Kobayashi Kyoko, Miyazaki Kana, Tawara Isao, Imai Hiroshi, Ono Ryoichi, Nosaka Tetsuya, Tanaka Kyosuke, Katayama Naoyu |
| Next generation sequencing of vitreoretinal lymphomas from small-volume intraocular liquid biopsies: new routes to targeted therapies. Oncotarget 2016 Dec . Cani Andi K, Hovelson Daniel H, Demirci Hakan, Johnson Mark W, Tomlins Scott A, Rao Rajesh |
| MYD88 L265P Mutations, But No Other Variants, Identify a Subpopulation of DLBCL Patients of Activated B-cell Origin, Extranodal Involvement, and Poor Outcome. Clinical cancer research : an official journal of the American Association for Cancer Research 2016 Jan . Rovira Jordina, Karube Kennosuke, Valera Alexandra, Colomer Dolors, Enjuanes Anna, Colomo Luis, Martinez-Trillos Alexandra, Gine Eva, Dlouhy Ivan, Magnano Laura, Delgado Julio, Martinez Antonio, Villamor Neus, Campo Elias, Lopez-Guillermo Arman |
| Non-invasive detection of somatic mutations using next-generation sequencing in primary central nervous system lymphoma. Oncotarget 2017 Jun . Fontanilles Maxime, Marguet Florent, Bohers Élodie, Viailly Pierre-Julien, Dubois Sydney, Bertrand Philippe, Camus Vincent, Mareschal Sylvain, Ruminy Philippe, Maingonnat Catherine, Lepretre Stéphane, Veresezan Elena-Liana, Derrey Stéphane, Tilly Hervé, Picquenot Jean-Michel, Laquerrière Annie, Jardin Fabri |
| TCL1A Single-Nucleotide Polymorphisms and Estrogen-Mediated Toll-Like Receptor-MYD88-Dependent Nuclear Factor-?B Activation: Single-Nucleotide Polymorphism- and Selective Estrogen Receptor Modulator-Dependent Modification of Inflammation and Immune Response. Molecular pharmacology 2017 08 92 (2): 175-184. Ho Ming-Fen, Ingle James N, Bongartz Tim, Kalari Krishna R, Goss Paul E, Shepherd Lois E, Mushiroda Taisei, Kubo Michiaki, Wang Liewei, Weinshilboum Richard |
| Clinical significance of disease-specific MYD88 mutations in circulating DNA in primary central nervous system lymphoma. Cancer science 2017 11 109 (1): 225-230. Hattori Keiichiro, Sakata-Yanagimoto Mamiko, Suehara Yasuhito, Yokoyama Yasuhisa, Kato Takayasu, Kurita Naoki, Nishikii Hidekazu, Obara Naoshi, Takano Shingo, Ishikawa Eiichi, Matsumura Akira, Hasegawa Yuichi, Chiba Shige |
| Detection of MYD88 and CXCR4 mutations in cell-free DNA of patients with IgM monoclonal gammopathies. Leukemia 2018 Jul . Bagratuni Tina, Ntanasis-Stathopoulos Ioannis, Gavriatopoulou Maria, Mavrianou-Koutsoukou Nefeli, Liacos Christine, Patseas Dimitrios, Kanellias Nikolaos, Migkou Magdalini, Ziogas Dimitrios C, Eleutherakis-Papaiakovou Evangelos, Roussou Maria, Fotiou Despina, Terpos Evangelos, Kastritis Efstathios, Dimopoulos Meletios |
| Role of germline aberrations affecting CTNNA1, MAP3K6 and MYD88 in gastric cancer susceptibility. Journal of medical genetics 2018 Jan . Weren Robbert D A, van der Post Rachel S, Vogelaar Ingrid P, van Krieken J Han, Spruijt Liesbeth, Lubinski Jan, Jakubowska Anna, Teodorczyk Urszula, Aalfs Cora M, van Hest Liselotte P, Oliveira Carla, Kamping Eveline J, Schackert Hans K, Ranzani Guglielmina N, Gómez García Encarna B, Hes Frederik J, Holinski-Feder Elke, Genuardi Maurizio, Ausems Margreet G E M, Sijmons Rolf H, Wagner Anja, van der Kolk Lizet E, Cats Annemieke, Bjørnevoll Inga, Hoogerbrugge Nicoline, Ligtenberg Marjolijn J |
| Mutations found in cell-free DNAs of patients with malignant lymphoma at remission can derive from clonal hematopoiesis. Cancer science 2019 8 110 (10): 3375-3381. Suehara Yasuhito, Sakata-Yanagimoto Mamiko, Hattori Keiichiro, Kusakabe Manabu, Nanmoku Toru, Sato Taiki, Noguchi Masayuki, Chiba Shige |
| Phase I study of tirabrutinib (ONO-4059/GS-4059) in patients with relapsed or refractory B-cell malignancies in Japan. Cancer science 2019 3 110 (5): 1686-1694. Munakata Wataru, Ando Kiyoshi, Hatake Kiyohiko, Fukuhara Noriko, Kinoshita Tomohiro, Fukuhara Suguru, Shirasugi Yukari, Yokoyama Masahiro, Ichikawa Satoshi, Ohmachi Ken, Gion Naokazu, Aoi Arata, Tobinai Kens |
| 98% IGHV gene identity is the optimal cutoff to dichotomize the prognosis of Chinese patients with chronic lymphocytic leukemia. Cancer medicine 2019 Dec . Shi Ke, Sun Qian, Qiao Chun, Zhu Huayuan, Wang Li, Wu Jiazhu, Wang Lili, Fu Jianxin, Young Ken H, Fan Lei, Xia Yi, Xu Wei, Li Jianyo |
| Dectin-1 rs3901533 and rs7309123 Polymorphisms Increase Susceptibility to Pulmonary Invasive Fungal Disease in Patients with Acute Myeloid Leukemia from a Chinese Han Population. Current medical science 2019 Dec 39 (6): 906-912. Chen Mei-Jing, Hu Rong, Jiang Xiao-Ying, Wu Yong, He Zhi-Peng, Chen Jing-Yi, Zhan |
| Genome-defined African ancestry is associated with distinct mutations and worse survival in patients with diffuse large B-cell lymphoma. Cancer 2020 May . Lee Michelle J, Koff Jean L, Switchenko Jeffrey M, Jhaney C Ileen, Harkins R Andrew, Patel Sharvil P, Dave Sandeep S, Flowers Christopher |
| CD79B Y196 mutation is a potent predictive marker for favorable response to R-MPV in primary central nervous system lymphoma. Cancer medicine 2022 Dec . Yamaguchi Junya, Ohka Fumiharu, Lushun Chalise, Motomura Kazuya, Aoki Kosuke, Takeuchi Kazuhito, Nagata Yuichi, Ito Satoshi, Mizutani Nobuhiko, Ohno Masasuke, Suzaki Noriyuki, Takasu Syuntaro, Seki Yukio, Kano Takahisa, Wakabayashi Kenichi, Oyama Hirofumi, Kurahashi Shingo, Tanahashi Kuniaki, Hirano Masaki, Shimizu Hiroyuki, Kitano Yotaro, Maeda Sachi, Yamazaki Shintaro, Wakabayashi Toshihiko, Kondo Yutaka, Natsume Atsushi, Saito Ryu |
| MYD88 and MYD88 variants show different molecular characteristics and prognostic significance in diffuse large B-cell lymphoma. Journal of cancer research and clinical oncology 2023 4 . Yan Qin, Tian Qiu, Zucheng Xie, Xinrui Chen, Peng Liu, Jianliang Yang, Xiaohui He, Lin Gui, Shengyu Zhou, Hongxin Jiang, Changgong Zhang, Sheng Yang, Le Tang, Yuankai S |
| Liquid Biopsies for Circulating Tumor DNA Detection May Reveal Occult Hematologic Malignancies in Patients With Solid Tumors. JCO precision oncology 2023 3 7 e2200583. Aldea Mihaela, Tagliamento Marco, Bayle Arnaud, Vasseur Damien, Vergé Véronique, Marinello Arianna, Danlos François-Xavier, Blanc-Durand Felix, Bernard Elsa, Cerbone Luigi, Mosele Maria Fernanda, Renneville Aline, Hadoux Julien, Loriot Yohann, Sakkal Madona, Vozy Aurore, Sarkozy Clementine, Smolenschi Cristina, Nicotra Claudio, Martin-Romano Patricia, Boccon-Gibod Clementine, Habza Wafikaamira, Lazarovici Julien, Ponce Santiago, Hollebecque Antoine, Marzac Christophe, Lacroix Ludovic, Barlesi Fabrice, André Fabrice, Besse Benjamin, Rouleau Etienne, Italiano Antoine, Micol Jean-Baptis |
| Whole-Exome Sequencing Revealed the Mutational Profiles of Primary Central Nervous System Lymphoma. Clinical lymphoma, myeloma & leukemia 2023 2 . Zhang Rui, Wei Boyuan, Hu Yiyang, Lv Wenying, Adilai Abudurexiti, Yang Fan, Zhang Jianning, Cheng Ga |
| Copy number variants landscape of multiple cancers and clinical applications based on NGS gene panel. Annals of medicine 2023 11 55 (2): 2280708. Kangpeng Yan, Li Niu, Boyu Wu, Chongwu He, Lei Deng, Chuan Chen, Zhangzhang Lan, Chao Lin, Weihua Kuang, Huihong Lin, Jun Zou, Wenyong Zhang, Zhiqiang L |
| Absence of BTK, BCL2, and PLCG2 Mutations in Chronic Lymphocytic Leukemia Relapsing after First-Line Treatment with Fixed-Duration Ibrutinib plus Venetoclax. Clinical cancer research : an official journal of the American Association for Cancer Research 2023 11 OF1-OF8. Nitin Jain, Lisa J Croner, John N Allan, Tanya Siddiqi, Alessandra Tedeschi, Xavier C Badoux, Karl Eckert, Leo W K Cheung, Anwesha Mukherjee, James P Dean, Edith Szafer-Glusman, John F Seymo |
| Mutational Landscape of Bone Marrow CD19 and CD138 Cells in Waldenström Macroglobulinemia (WM) and IgM Monoclonal Gammopathy of Undetermined Significance (IgM MGUS). Cancer medicine 2024 12 13 (24): e70525. Alessandra Trojani, Alessandro Beghini, Luca Emanuele Bossi, Marta Rachele Stefanucci, Cassandra Palumbo, Antonino Greco, Annamaria Frustaci, Barbara Di Camillo, Roberto Cairo |
| Clinicopathological and genetic analyses of thyroid large B-cell lymphoma in a Japanese population. Journal of clinical and experimental hematopathology : JCEH 2024 10 . Ayumi Numata, Rika Sakai, Kae Kawachi, Yasufumi Ishiyama, Yukako Hattori, Hirotaka Takasaki, Tomoyuki Yokose, Naoya Nakamura, Hideaki Nakaji |
| Zanubrutinib plus R-CHOP for the treatment of newly diagnosed double-expressor lymphoma: A phase 2 clinical study. Cancer 2025 1 131 (1): e35697. Xia Yin, Qiang He, Dan Liu, Linna Xie, Hui Wang, Chunyan Chen, Chuanli Zhao, Ningning Shan, Shanshan Shi, Haichen Wei, Ji Ma, Ke Lu, Liang Wang, Yan Wang, Lijie Xing, Zengjun |
- Page last reviewed:Feb 1, 2024
- Content source: